The government accused Walmart pharmacies of failing to confirm and document the necessary diagnoses for “Code 1” drugs and then billing the Medi-Cal program for the prescriptions. Medi-Cal provides reimbursement for certain “Code 1” drugs only for approved diagnoses, and pharmacies serve as gatekeepers in this process.
“These Medi-Cal regulations are essential to protect both patients and limited healthcare funding,” said U.S. Attorney Phillip A. Talbert. “My office will continue to hold pharmacies accountable when they fail to comply with regulations like these.”
The allegations against Walmart were originally brought under the qui tam, or whistle-blower, provisions of the False Claims Act by a Walmart pharmacist.
More articles on legal and regulatory issues:
8 latest lawsuits involving hospitals
Reliant Care Group to pay $8.3M to resolve false claims allegations
Hospice company settles false billing case for $2M
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.